Total Payments
$2,751
2024 Payments
$883.38
Companies
13
Transactions
134
Medicare Patients
2,144
Medicare Billing
$127,928
Payment Breakdown by Category
Food & Beverage$2,661 (96.7%)
Education$90.00 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,661 | 133 | 96.7% |
| Education | $90.00 | 1 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $947.96 | 38 | $0 (2024) |
| Merck Sharp & Dohme LLC | $326.36 | 19 | $0 (2024) |
| PFIZER INC. | $318.50 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $297.83 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $259.70 | 11 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $186.72 | 14 | $0 (2021) |
| Amarin Pharma Inc. | $136.33 | 8 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $123.40 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $37.09 | 2 | $0 (2024) |
| Abbott Laboratories | $36.10 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $883.38 | 44 | AstraZeneca Pharmaceuticals LP ($298.01) |
| 2023 | $609.23 | 31 | Merck Sharp & Dohme LLC ($162.16) |
| 2022 | $531.34 | 23 | AstraZeneca Pharmaceuticals LP ($184.56) |
| 2021 | $727.07 | 36 | AstraZeneca Pharmaceuticals LP ($305.13) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.83 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.31 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 665 | 940 | $140,719 | $40,147 |
| 2022 | 2 | 507 | 696 | $111,315 | $32,397 |
| 2021 | 2 | 464 | 630 | $99,378 | $28,417 |
| 2020 | 3 | 508 | 697 | $113,375 | $26,967 |
Total Patients
2,144
Total Services
2,963
Medicare Billing
$127,928
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 433 | 669 | $133,131 | $38,824 | 29.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 232 | 271 | $7,588 | $1,323 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 385 | 537 | $106,863 | $31,586 | 29.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 122 | 159 | $4,452 | $811.08 | 18.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 341 | 478 | $95,122 | $27,675 | 29.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 123 | 152 | $4,256 | $742.14 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 384 | 542 | $107,858 | $25,893 | 24.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 113 | 144 | $4,032 | $735.98 | 18.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $1,485 | $337.90 | 22.8% |
About Jenni Wade, FNP-C
Jenni Wade, FNP-C is a Family healthcare provider based in Thomasville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1821473885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenni Wade, FNP-C has received a total of $2,751 in payments from pharmaceutical and medical device companies, with $883.38 received in 2024. These payments were reported across 134 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,661).
As a Medicare-enrolled provider, Wade has provided services to 2,144 Medicare beneficiaries, totaling 2,963 services with total Medicare billing of $127,928. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Thomasville, GA
- Active Since 07/20/2015
- Last Updated 11/19/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1821473885
Products in Payments
- FARXIGA (Drug) $772.94
- ELIQUIS (Drug) $335.76
- VERQUVO (Drug) $326.36
- JARDIANCE (Drug) $259.70
- LEQVIO (Drug) $197.25
- Livalo (Drug) $186.72
- Vascepa (Drug) $136.33
- XARELTO (Drug) $123.40
- ENTRESTO (Drug) $100.58
- LifeVest (Device) $34.18
- Barostim Neo System (Device) $30.05
- CardioMEMS HF System (Device) $24.17
- WAINUA (Drug) $22.98
- CAMZYOS (Drug) $19.83
- Repatha (Biological) $16.80
- HeartMate 3 Left Ventricular Assist Device (Device) $11.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Thomasville
Daniel Bonner, Np-C, NP-C
Family — Payments: $4,923
Family $4,923
Mrs. Lori Love, Fnp-C, FNP-C
Family — Payments: $4,283
Family $4,283
Kaycie Langston
Family — Payments: $3,572
Family $3,572
Kristin Deutsch, N.p, N.P
Family — Payments: $3,445
Family $3,445
Amber Rodd, Aprn, APRN
Family — Payments: $2,615
Family $2,615
Regenia Hutchins, Np, NP
Family — Payments: $2,614
Family $2,614